Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,254Revenue (TTM) $M2,018Net Margin (%)5.3Altman Z-Score3.9
Enterprise Value $M3,936EPS (TTM) $3.7Operating Margin %7.8Piotroski F-Score7
P/E(ttm)39.5Beneish M-Score-2.3Pre-tax Margin (%)6.9Higher ROA y-yY
Price/Book1.610-y EBITDA Growth Rate %4.5Quick Ratio3.1Cash flow > EarningsY
Price/Sales2.15-y EBITDA Growth Rate %-7.7Current Ratio4.4Lower Leverage y-yY
Price/Free Cash Flow109y-y EBITDA Growth Rate %-6.4ROA % (ttm)3.0Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)4.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M29.4ROIC % (ttm)5.8Gross Margin Increase y-yY

Gurus Latest Trades with BIO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIOPrivate Capital 2016-03-31 Sold Out -0.25%$123.93 - $138.97
($131.21)
$ 144.7210%Sold Out0
BIOJoel Greenblatt 2016-03-31 Reduce-0.04%$123.93 - $138.97
($131.21)
$ 144.7210%Reduce -25.83%67,705
BIONWQ Managers 2016-03-31 Reduce-0.01%$123.93 - $138.97
($131.21)
$ 144.7210%Reduce -0.78%422,546
BIOKen Fisher 2016-03-31 Reduce$123.93 - $138.97
($131.21)
$ 144.7210%Reduce -2.02%269,075
BIOJohn Rogers 2016-03-31 Reduce$123.93 - $138.97
($131.21)
$ 144.7210%Reduce -0.14%1,004,492
BIOMario Gabelli 2016-03-31 Reduce$123.93 - $138.97
($131.21)
$ 144.7210%Reduce -0.75%66,500
BIONWQ Managers 2015-12-31 Reduce-0.04%$134.34 - $141.7
($138.69)
$ 144.724%Reduce -4.00%425,876
BIOJoel Greenblatt 2015-12-31 Reduce-0.03%$134.34 - $141.7
($138.69)
$ 144.724%Reduce -21.15%91,287
BIOGeorge Soros 2015-12-31 Sold Out -0.01%$134.34 - $141.7
($138.69)
$ 144.724%Sold Out0
BIOJohn Rogers 2015-12-31 Add0.01%$134.34 - $141.7
($138.69)
$ 144.724%Add 0.58%1,005,947
BIOMario Gabelli 2015-12-31 Reduce$134.34 - $141.7
($138.69)
$ 144.724%Reduce -1.76%67,000
BIOPrivate Capital 2015-12-31 Reduce$134.34 - $141.7
($138.69)
$ 144.724%Reduce -1.87%14,402
BIOKen Fisher 2015-12-31 Reduce$134.34 - $141.7
($138.66)
$ 144.724%Reduce -0.32%274,634
BIOJohn Rogers 2015-09-30 Reduce-0.21%$133.19 - $151.93
($144.02)
$ 144.720%Reduce -10.94%1,000,161
BIONWQ Managers 2015-09-30 Reduce-0.11%$133.19 - $151.93
($144.02)
$ 144.720%Reduce -10.84%443,605
BIOJoel Greenblatt 2015-09-30 Reduce-0.01%$133.19 - $151.93
($144.02)
$ 144.720%Reduce -6.85%115,771
BIOGeorge Soros 2015-09-30 Buy 0.01%$133.19 - $151.93
($144.02)
$ 144.720%New holding2,200
BIOMario Gabelli 2015-09-30 Reduce$133.19 - $151.93
($144.02)
$ 144.720%Reduce -1.02%68,200
BIOKen Fisher 2015-09-30 Reduce$133.19 - $151.93
($144.02)
$ 144.720%Reduce -3.74%275,519
BIOJoel Greenblatt 2015-06-30 Reduce-0.18%$134.45 - $151.23
($142.94)
$ 144.721%Reduce -58.42%124,281
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BIO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Magni GiovanniEVP, Chief Strategy Officer 2014-12-12Sell5,000$117.3823.29view
SODERBERG SHAWN MARIEEVP, General Counsel, Sec 2014-12-03Sell83$12020.6view
HERTIA JOHNExecutive Vice President 2014-11-25Sell6,000$119.3921.22view
TSINGOS CHRISTINE AEVP and CFO 2014-11-20Sell1,326$115.8524.92view
GOETZ JOHNEVP, COO 2014-11-19Sell4,891$114.4126.49view
HUTTON RONALD WVice President and Treasurer 2014-11-13Sell3,066$111.6229.65view
SCHWARTZ STEVEN D10% Owner 2014-11-13Sell530$111.9329.3view
TSINGOS CHRISTINE AEVP and CFO 2014-11-12Sell7,000$112.2228.96view
STARK JAMES RVP, Corporate Controller 2014-11-11Sell4,257$112.628.53view

Press Releases about BIO :

Quarterly/Annual Reports about BIO:

News about BIO:

Articles On GuruFocus.com
Royce 100 Fund Shareholder Letter Sep 20 2015 
Widely Held Guru Stocks Near Historical Low P/B Ratios Aug 11 2014 
Guru Held Stocks Near Historical Low P/B Jul 22 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Jun 02 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 27 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 19 2014 
Morning Coffee: Widely Held Guru Stocks Near Historic Low P/B May 12 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Apr 23 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Apr 14 2014 
Different Opinions on Bio-Rad Laboratories Apr 03 2014 

More From Other Websites
Bio-Rad Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : BIO-US : July... Jul 27 2016
Bio-Rad Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : BIO-US : July... Jul 13 2016
Bio-Rad to Report Second-Quarter 2016 Financial Results Wednesday, August 3, 2016 Jul 11 2016
Bio-Rad to Report Second-Quarter 2016 Financial Results Wednesday, August 3, 2016 Jul 11 2016
ETF’s with exposure to Bio-Rad Laboratories, Inc. : June 20, 2016 Jun 20 2016
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Bio-Rad Laboratories, Inc. for... Jun 20 2016
Bio-Rad Laboratories, Inc. – Value Analysis (NYSE:BIO) : June 17, 2016 Jun 17 2016
Bio-Rad Laboratories, Inc. breached its 50 day moving average in a Bearish Manner : BIO-US : June... Jun 16 2016
Bio-Rad Unveils Amplichek II Quality Control, the First in a Series of Controls for the Molecular... May 23 2016
Bio-Rad Unveils Amplichek II Quality Control, the First in a Series of Controls for the Molecular... May 23 2016
ETF’s with exposure to Bio-Rad Laboratories, Inc. : May 19, 2016 May 19 2016
Bio-Rad Laboratories, Inc. :BIO-US: Earnings Analysis: Q1, 2016 By the Numbers May 17 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of... May 16 2016
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Bio-Rad Laboratories, Inc. for... May 16 2016
BIO RAD LABORATORIES INC Financials May 14 2016
BIO RAD LABORATORIES INC Files SEC form 10-Q, Quarterly Report May 06 2016
Edited Transcript of BIO earnings conference call or presentation 5-May-16 9:00pm GMT May 06 2016
Bio-Rad Reports First-Quarter 2016 Currency-Neutral Revenue Growth of Nearly 4 Percent May 05 2016
BIO RAD LABORATORIES INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 05 2016
Bio-Rad posts 1Q profit May 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)